Skip to main navigation Skip to search Skip to main content

Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of Japanese encephalitis infections

  • Andrea J. Cuzzubbo
  • , Timothy P. Endy
  • , David W. Vaughn
  • , Tom Solomon
  • , Ananda Nisalak
  • , Siripen Kalayanarooj
  • , Nguyen Minh Dung
  • , David Warrilow
  • , John Aaskov
  • , Peter L. Devine
  • PanBio Pty. Ltd.
  • Armed Forces Research Institute of Medical Sciences, Thailand
  • Walter Reed Army Institute of Research
  • Wellcome Trust Clin. Research Unit
  • University of Liverpool
  • Thailand Ministry of Public Health
  • Cho Quan Hospital
  • Queensland University of Technology
  • Royal Children's Hospital Brisbane

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Abstract

A new commercial enzyme-linked immunosorbent assay (ELISA) for the diagnosis of Japanese encephalitis virus infections showed a sensitivity of 88% with sera and 81% with cerebrospinal fluid and a specificity of 97% with sera from patients with primary and secondary dengue virus infections. Specificity was 100% when samples from nonflavivirus infections were tested.

Original languageEnglish
Pages (from-to)3738-3741
Number of pages4
JournalJournal of Clinical Microbiology
Volume37
Issue number11
DOIs
StatePublished - Nov 1999

Fingerprint

Dive into the research topics of 'Evaluation of a new commercially available immunoglobulin M capture enzyme-linked immunosorbent assay for diagnosis of Japanese encephalitis infections'. Together they form a unique fingerprint.

Cite this